Updates | Pfizer

Gender Differences in Coping with Migraine

Read more about Gender Differences in Coping with Migraine

Imagine having a condition that impacts your everyday life and realizing your gender could shape your experience and approach to managing it. This is the reality for many with migraine, as revealed in a recent episode of the National Headache Foundation (NHF) InSights podcast hosted by Pfizer.

Pfizer Sites Across the U.S. Commemorate Juneteenth

Read more about Pfizer Sites Across the U.S. Commemorate Juneteenth

Last month, in recognition of Juneteenth, Pfizer’s Global Black Community (GBC) colleague resource group commemorated the recently enacted Federal holiday with a collection of events at Pfizer sites across the country.

June Social Media Round-Up—Pride, 175, and “What’s in My Lab?”

Read more about June Social Media Round-Up—Pride, 175, and “What’s in My Lab?”

Pfizer welcomed summer with another busy month. In June, our leadership reflected on Pfizer’s 175 years of history, celebrated Pride Month and Juneteenth, and supported Pfizer’s dedication to fighting cancer. Check out our monthly round-up.

Opportunities to Drive Change in Alopecia Areata

Read more about Opportunities to Drive Change in Alopecia Areata

A disease doesn’t have to be life-threatening to be life changing. Alopecia areata (AA), an autoimmune disease that causes hair loss, typically on the head and face, is a perfect example.

Pfizer Launches 175 Days of Good—A Global Commitment to Community Volunteerism

Read more about Pfizer Launches 175 Days of Good—A Global Commitment to Community Volunteerism

Building on Pfizer’s 175-year legacy to be a force for good in the world, Pfizer launched 175 Days of Good—a global call to action to inspire and celebrate colleague volunteerism and Pfizer’s collective commitment to do good where we work, live—and beyond.

Pfizer’s Global Asian Alliance Colleague Resource Group Celebrates Asian American Native Hawaiian Pacific Islander (AANHPI) Heritage Month

Read more about Pfizer’s Global Asian Alliance Colleague Resource Group Celebrates Asian American Native Hawaiian Pacific Islander (AANHPI) Heritage Month

The theme of this May’s Asian American Native Hawaiian Pacific Islander (AANHPI) Heritage Month is “We Lead Together!”, and it’s one that Pfizer heartily endorses as we continue to strive for equity and celebrate diversity across all aspects of our business.

2024 Pride Journal—Together in Pride

Read more about 2024 Pride Journal—Together in Pride

As an ally for the LGBTQ+ community, I am both honoured and delighted to have been asked to contribute the foreword for this year’s OPEN Global Pride Journal. In considering the words to share with you, it has given me time to reflect on this year’s theme of "Together in Pride" and what this means for our colleagues, culture and values, and the role I can play.

May Social Media Round-Up—Clinicals Trials Day, the TIME 100, and the Future of Cancer Care

Read more about May Social Media Round-Up—Clinicals Trials Day, the TIME 100, and the Future of Cancer Care

The month of May not only brought flowers, but also noteworthy celebrations at Pfizer. Take a moment to catch up on social posts from our corporate channels.

Pfizer Receives Positive CHMP Opinion for its One-Time Gene Therapy for Adults with Hemophilia B

Read more about Pfizer Receives Positive CHMP Opinion for its One-Time Gene Therapy for Adults with Hemophilia B

NEW YORK, May 31, 2024 – Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for fidanacogene elaparvovec, a gene therapy for the treatment of severe and moderately severe hemophilia B (congenital factor IX deficiency) in adult patients without a history of factor IX inhibitors and without detectable antibodies to variant AAV serotype Rh74.

Pfizer Showcases New Data Across its Broadened Oncology Portfolio at ASCO Annual Meeting

Read more about Pfizer Showcases New Data Across its Broadened Oncology Portfolio at ASCO Annual Meeting

With one in five people facing a cancer diagnosis in their lifetime, the disease touches everyone’s life in some way. If the numbers tell us anything, it’s that cancer isn’t slowing down – and neither is Pfizer.

Subscribe to Updates